(Phys.org)—The United States Patent and Trademark Office (USPTO) officially agreed this past Monday to wobble forward with interference hearings regarding the case of the true inventor of the CRISPR/Cas9 gene editing technique. This sets the stage for a major battle between two groups of scientists, their affiliated institutions and supporters backing one or the other who hope to reap large financial rewards from its employ.
Source: phys.org